Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
08/2008
08/27/2008CN100413969C Chimeric gene with delta 6 fatty acid dehydrogenase function and its use
08/27/2008CN100413968C P450BM-3Glue435Thr variant gene capable of catalyzing indole to generate indigo blue and its use
08/27/2008CN100413967C (R)-2-octanol dehydrogenase, process for producing enzyme, DNA encoding enzyme and process for producing alcohol by using same
08/27/2008CN100413964C Linear expression carrier construction method need no clone
08/27/2008CN100413885C Modified proteins, designer toxins and methosd of making thereof
08/27/2008CA2617702A1 Quinones as mediators for photometric tests
08/26/2008US7417180 Genes for increasing grain yield and uses thereof
08/26/2008US7417178 Expression of human milk proteins in transgenic plants
08/26/2008US7417176 Diacylglycerol acyltransferase nucleic acid sequences and associated products
08/26/2008US7417135 Expression vector comprising nucleotide sequences coding lytic enzyme for use as gene transfer tool in generating transgenic lactobacillus with enhanced amylase activity; improving digestibility of animal feeds
08/26/2008US7417133 Methods for obtaining thermostable enzymes, DNA polymerase I variants from Thermus aquaticus having new catalytic activities, methods for obtaining the same, and applications of the same
08/26/2008US7417131 Modified green fluorescent proteins and methods for using same
08/26/2008US7417125 Chimeric humanized monoclonal antibody for treating tumors and inflammation
08/26/2008US7417123 PRO4399 Antibodies
08/26/2008US7417115 For stimulating release of tumor necrosis factor and/or cellular differentiation of chondrocytes, endothelial cells or adipocytes by contacting blood with pro-polypeptide; cancer diagnosis and treatment
08/26/2008US7417024 template-fixed beta -hairpin peptidomimetics incorporating a template-fixed chain of 7 or 11 alpha -amino acid residues which, depending on their position in the chain, are Gly, or Pro, or of certain types; inhibitors of various serine proteases such as trypsin, human cathepsin G, and thrombin
08/26/2008US7416876 polypeptides having amino acid sequences, which catalyzes the removal of protection groups from amino acids and alcohols
08/26/2008US7416875 modified to be cytotoxic by altering its amino acid sequence so that it is not bound easily by the ribonuclease inhibitor while still retaining catalytic properties
08/26/2008US7416874 For use in food and feeds
08/26/2008US7416873 Such as the Abl tyrosine kinase domain; leukemia
08/26/2008US7416872 Taxoid oxygenases and their uses
08/26/2008US7416871 Thermo-stable lactate oxidase
08/26/2008US7416870 Methods of directing C-O bond formation utilizing a type II polyketide synthase system
08/26/2008US7416869 Polyglycerols; cosmetics; for recreational water supply
08/26/2008US7416868 polypeptide comprising an amino acid sequence having polyene polyketide synthase activity; involved in the biosynthesis of novel polyketides, inhibitors of fungal cell growth and cancer cell growth
08/26/2008US7416867 partial (meth)acrylic esters of polyalcohols can be prepared in high conversions and with high purities from simple reactants. The synthesis ought to proceed under mild conditions, giving products having a low color number and high purity
08/26/2008US7416866 Using transgenic bacteria to ferment 3-keto steroid Delta 1-dehydrogenase for use in selective dehydrogenation of steroids
08/26/2008US7416865 Stereoselective; reduction and esterification (in either order) of 2,3-dihydroxybutyrylalkanoic acid ester in the presence of a lipase or hydrolase, preferably of microorganism origin
08/26/2008US7416861 Human coagulation factor VII polypeptides
08/26/2008US7416860 Expression vector comprising nucleotide sequences coding blood coagulation factor for use as heterologous gene expression tool; treating blood disorders; bioreactor for producing secreted proteins
08/26/2008US7416858 Forming a convalent conjugate of a peptide, removing X2 or a saccharyl subunit thereof from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety
08/26/2008US7416855 Comprises nucleotide sequences coding enzymatic polypeptide associated with programed cell death for identifying modulators for treatment of inflammatory, neurodegenerative and cell proliferative disorders
08/26/2008US7416853 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
08/26/2008US7416730 Derivatives of the IL-2 receptor gamma chain, their production and use
08/26/2008CA2432129C Pyrazole compounds useful as protein kinase inhibitors
08/26/2008CA2374667C Synthetic ligation reassembly in directed evolution
08/26/2008CA2343880C Polyketide synthase enzymes and recombinant dna constructs therefor
08/26/2008CA2325798C A process for producing isoprenoid compounds by microorganisms and a method for screening compounds with antibiotic or weeding activity
08/26/2008CA2295190C Improved protein expression strains
08/26/2008CA2235225C Nima interacting proteins
08/21/2008WO2008100251A1 Modified microorganism uses therefor
08/21/2008WO2008100021A1 Genes which are related to trehalose biosynthesis and mass-production of trehalose using thereof
08/21/2008WO2008099928A1 Placental protein having action of regulating protease activity and its related gene
08/21/2008WO2008099898A1 Transglutaminase having disulfide bond introduced therein
08/21/2008WO2008099094A2 Phytase having an arginine in its catalytic site for the hydrolysis of phytic acid into non-organic monophosphate and free myoinositol
08/21/2008WO2008098975A1 Truncated alternansucrase coding nucleic acid molecules
08/21/2008WO2008098973A1 Coagulation of milk
08/21/2008WO2008098377A1 Serpine1 polymorphisms are predictive of response to activated protein c administration and risk of death
08/21/2008WO2008098368A1 Inhibitors of hepatitis c ns3 protease
08/21/2008WO2008098320A1 Arabinoxylo-oligosaccharides in beer
08/21/2008WO2008083065A3 A recombinant type ii restriction endonuclease, nmeaiii, and a process for producing the same
08/21/2008WO2008079228A9 Assays for improved fungal strains
08/21/2008WO2008076322A3 Novel laccases, compositions and methods of use
08/21/2008WO2008076322A2 Novel laccases, compositions and methods of use
08/21/2008WO2008068048A3 A novel passive vaccine for candida infections
08/21/2008WO2008054945A9 Enduracidin biosynthetic gene cluster from streptomyces fungicidicus
08/21/2008WO2008045273A3 Camkk(beta) as a target for treating obesity
08/21/2008WO2008024457A3 Rnase a peptides, fragments and uses thereof
08/21/2008WO2008011468A3 Fatty acid desaturases from tetraselmis suecica
08/21/2008US20080201807 Gelatinization Temperature Manipulation
08/21/2008US20080201805 Polypeptides Having Beta-Glucosidase Activity and Polynucleotides Encoding Same
08/21/2008US20080201802 Transgenic plant which expresses linoleic acid desaturase for use in controlling alpha-linolenic acid content in structural lipids or storage oils
08/21/2008US20080201799 Protein kinase stress-related proteins and methods of use in plants
08/21/2008US20080201790 Method and product for regulating cell responsiveness to external signals
08/21/2008US20080201788 Rodent animal model having decreased or deleted activity of an enzyme relating to modification of sugar chain in which 1-position of fucose is bound to 6-position of N-acetylglucosamine; targeting medicants to 1,6-fucosyltransferase
08/21/2008US20080200662 Nucleotide sesequences coding hydroperoxide lyase for use in preserving food flavor and odor
08/21/2008US20080200659 Combinatorial polyketide libraries produced using a modular PKS gene cluster as scaffold
08/21/2008US20080200649 Method
08/21/2008US20080200646 and cerebral ischemia and or the onset of systemic inflammatory response particularly when associated with a surgical procedure(especially cardiothoracic surgery; kit comprising a dry lyophilized kallikrein inhibitor DX88 in a hermetically sealed container (rather than aprotinin)
08/21/2008US20080200458 Inhibiting Delta 5-desaturase by contacting Delta 5-desaturase with a compound such as N-(3-chlorophenyl)thieno[3,2-d]pyrimidin-4-amineor a pharmaceutically acceptable salt or solvate thereof; treating, preventing and managing disorders e.g., obesity, diabetes
08/21/2008US20080200439 Establishing a test sample comprising a myocyte BK channel beta 1 subunit and measuring the interaction, effect, or combination thereof, of a candidate composition on test sample to thereby determine ability of candidate composition to modulate myocyte BK channel activity
08/21/2008US20080200415 Plant Activation of Insect Toxin
08/21/2008US20080200386 Compositions and methods for the therapy and diagnosis of breast cancer
08/21/2008US20080200363 Perfumes, brighteners, insect repellants, flavors, vitamins, fabric softeners, skin care agents; increasing potency, reducing cost
08/21/2008US20080199942 Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast
08/21/2008US20080199940 Cosmids; vectors; prokaryotics; Micromonospora biosynthesis
08/21/2008US20080199938 Glucanse comprising substituted amino acids for use in enhancing detergents and improving the touch and/or appearance of cellulose-containing fabric
08/21/2008US20080199937 Reagent Composition and Methods of Using and Forming the Same
08/21/2008US20080199936 FEN Endonucleases
08/21/2008US20080199935 Trangenic synthetase deficient in 3' to 5' exonuclease activity and/or exhibit reduced discrimination against non-conventional nucleotide for use as in situ mutagenic tools; directed protein evolution
08/21/2008US20080199934 Adding functional groups to peptides for use in preparation of muscle and silk protein
08/21/2008US20080199933 Amine Oxidase Inhibitors
08/21/2008US20080199921 Process for producing glutamate derivatives
08/21/2008US20080199920 From L-lysine
08/21/2008US20080199918 Using glycoside hydrolase digestion to produce soluble starch hydrolysate which later converted to high fructose starch-based syrup
08/21/2008US20080199912 Methods for Obtaining Optically Active Epoxides and Diols from 2,3-Disubstituted and 2,3-Trisubstituted Epoxides
08/21/2008US20080199905 Catalyze formation of oligosaccharides in presence of magnesium; increasing immunogenicity of antigen; expression cassettes, cells
08/21/2008US20080199897 Reporter molecules
08/21/2008US20080199895 Mixture comprising adenosine triphosphatase for use in identifying modulators for treatment and prevention of congestive heart failure
08/21/2008US20080199874 Controllable strand scission of mini circle dna
08/21/2008US20080199860 Variants of the alpha 1 subunit of human ampk
08/21/2008US20080199848 Method For Determining the Concentration of Asymmetric Dimethylarginine (Adma)
08/21/2008US20080199514 Nucleotide polymorphism in gene coding; causing mutants; prevents binding; useful for diagnosis, therapy
08/21/2008US20080199496 Protein disulfide isomerase for therapy, detection, prevention of leishmaniasis; parasiticides
08/21/2008US20080199447 Metalloprotease catalytic site for use in identifying modulators for prevention and treatment of respiratory system disorders
08/21/2008US20080199442 Gene linked to control elements capable of directing in vivo transcription and translation; systemic delivery of erythropoietin
08/21/2008US20080199425 Administering monophenol or benzenediol compounds which modify tyrosinase proteins; stimulate inflammatory response; 4-tertiary butylphenol, fludarabine and cyclophosphamide
08/21/2008US20080196173 Novel Laccases, Compositions And Methods of Use
08/21/2008CA2678436A1 Serpine1 polymorphisms are predictive of response to activated protein c administration and risk of death
08/21/2008CA2677911A1 Method of detecting equine polysaccharide storage myopathy